Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia

NCT07036809 is registered in ClinicalTrials.gov with Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy as lead sponsor.

NCT NCT07036809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07036809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia
Lead sponsor
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Phase
Observational
Overall status
Completed
Start date
June 1, 2023
Completion date
October 1, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia